NorthWest Biotherapeutics Inc (NWBO)

[ELecsol28]

11:00 DCVAX®: NOVEL PERSONALISED IMMUNE THERAPIES FOR SOLID TUMOURS

Linda Powers
Linda Powers, CEO, Northwest Biotherapeutics Inc

• DCVax® is a fully personalised precision medicine, tailored to the individual patient and their tumour
• DCVax® is designed to mobilise many active agents of the immune system to hit many targets on the cancer, unlike conventional cancer drugs and some other immune therapies, which generally use a single active agent to hit a single target on the cancer
• A full course of DCVax® doses can be manufactured in a single batch within about a week, and can be stored frozen until needed (including for years)